Stock screener

TXG

Conviction 80IndustrialsScan · Thu, Jun 25, 2026
TXG$35.71+3.19%
ResistanceSupportVol 14Insider sell
63 bars
4
2
3
Vol MA14 3.37M
Mar 26Apr 14May 1May 19Jun 8Jun 25
10x Genomics, Inc.LABORATORY ANALYTICAL INSTRUMENTSwww.10xgenomics.com
Price35.71
Change+3.19%
Gap+0.49%
Rel volume0.80×
Avg volume3.36M
Avg $ vol105.46M
SMA 2031.30
SMA 5026.14
SMA 20019.50
Price vs 50+36.62%
Price vs 200+83.08%
MA stackbullish
50/200 cross
Supertrendup · 28.18
RSI (14)67
MACD hist0.21
MACD crossbull · 7d
Stoch %K / %D87 / 70
ADX (14)38
+DI / −DI37 / 12
RSI divergenceBearish
MACD divergenceBearish
ATR %+6.65%
ADR %7.80%
52w high35.71
52w low11.34
From 52w high+0.00%
Above 52w low+214.86%
New 52w highYes
SqueezeOff
Bollinger width28.10%
%B1.00
Donchian pos90.48%
Donchian high36.81
Donchian low25.20
AVWAP (52w high)35.71
vs AVWAP high-0.01%
AVWAP (52w low)18.10
vs AVWAP low+97.32%
OBV trendUp
Chaikin MF (20)0.04
Today vs 20d0.80×
Avg vol (14d)3.37M
Avg vol (20d)3.36M
Avg $ vol (20d)105.46M
Market cap4.56B
RS 3m (vs SPY)+62.40%
RS 6m (vs SPY)+107.84%
RS line new highYes
Trend template8/8
Technical rank96.2
1 week+11.13%
1 month+45.02%
3 months+70.76%
6 months+110.77%
1 year+227.87%
YTD+114.83%
P/E-104.70
P/B5.60
P/S7.09
P/FCF35.04
EPS-0.3500
Div yield
ROE-5.35%
ROA-4.29%
Debt/Eq0.00
Current5.90
EV/EBITDA-170.06
Gross margin69.05%
Net margin-6.77%
Rev growth5.25%
EPS growth76.16%
Price target25.75
Target upside-27.88%
Analyst ratingHold
Institutional119.44%
Ent. value4.22B
Revenue150.84M
Net income-13.47M
Gross profit106.18M
Free cash flow130.12M
IndustryLABORATORY ANALYTICAL INSTRUMENTS
ExchangeNasdaq
Shares out116.88M
Employees1.18K
ListedThu, Sep 12, 2019
Free float113.98M
Float %96.9%
Short interest16.49M
Days to cover5.5d
Short volume47.4%
Squeeze score59 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.23 · 6 est
Last EPS vs est−$0.10 vs −$0.29
Last surprise+65.5% beat
Setup gradeA
Conviction80 / 100
Pattern quality
Tech rank96.2 / 100
Group rank77 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance36.12
Support21.43
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TXG

All disclosures →
No recent disclosed trades by Congress in TXG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TXG · 3 buys · 6 sells

InsiderSideShares
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-06-22
Sell9.82K
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-06-22
Sell1.66K
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-06-22
Sell8.53K
Saxonov Serge
Chief Executive Officer · Class A Common Stock · 2026-06-22
Sell9.99K
SULIMAN SHEHNAAZ
Director · Class A Common Stock · 2026-06-16
Sell5.36K
SULIMAN SHEHNAAZ
Director · Class A Common Stock · 2026-06-16
Sell364
Kosaraju Sridhar
Director · Class A Common Stock · 2026-06-04
Grant8.83K
MATEO ALAN
Director · Class A Common Stock · 2026-06-04
Grant8.83K
Kosaraju Sridhar
Director · Class A Common Stock · 2026-06-04
Other
Teichmann Sarah A.
Director · Class A Common Stock · 2026-06-04
Grant8.83K

SEC filings

EDGAR filings in TXG · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.